Name | Molecular mass (g/mol) | Selective Target | FDA approved | Cancer (example) |
Afatinib | 485.94 | HER2, EGFR | Yes | Squamous cell arcinoma 0f head and neck, breast cancer |
Crizotinib | 450.34 | MET | Yes | Anaplastic large cell lymphoma, Neuroblastoma |
Eroltinib | 393.43 | EGFR | Yes | NSCLC, AML |
Icotinib | 391.15 | RGFR | Yes | NSCLC |
Lepatinib | 581.06 | HER2, EGFR | Yes | Breast cancer |
Lenvatinib | 426.85 | VEGFR 2,3 | Yes | Thyroid cancer |